Expired activity
Please go to the PowerPak homepage and select a course.

Incorporating Hematopoietic Growth Factor Biosimilars into the Treatment of Cancer: Best Practices for Oncology Pharmacists (Podcast)

» References (PDF)

FACULTY

Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP
Clinical Professor, Pharmacy Practice
UConn School of Pharmacy
Storrs, CT

Oncology Pharmacy Specialist
UConn Health Carole and Ray Neag Comprehensive Cancer Center
Farmingdale, CT

LEARNING OBJECTIVES

Upon completion of this program, participants should be better able to:

  • Identify current and emerging issues and challenges of incorporating hematopoietic growth factor biosimilars into practice
  • Identify common myths patients have about biosimilars and explain how to dispel these myths so patients will have a better understanding of biosimilars in order to effectively participate in shared treatment decision-making

Back to Top